[Lipid metabolism diseases].
Schwandt
Peter
P
Arteriosklerose-Präventions-Institut, Wilbrechtstr. 95, 81477 München. API.Schwandt.Haas@t-online.de
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D050356:Lipid Metabolism; D008661:Metabolism, Inborn Errors / Q000188:drug therapy / Q000378:metabolism*; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents